[Clinical characteristics of withdrawal from insulin therapy in NIDDM].
Kanda
T
T
Department of Internal Medicine, Osaka Prefectural General Hospital.
Imano
E
E
Iida
M
M
Kawamori
R
R
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control; D003927:Diet, Diabetic; D005081:Exercise Therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage; D007333:Insulin Resistance; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*
D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds